The gut mycobiome: The overlooked constituent of clinical outcomes and treatment complications in patients with cancer and other immunosuppressive conditions

• Jessica R. Galloway-Peña ,

  * E-mail: jrgalloway@mdanderson.org (JRG-P); dkontoyi@mdanderson.org (DPK)

  Affiliations Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America, Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  http://orcid.org/0000-0003-1081-254X

  ⨯
• Dimitrios P. Kontoyiannis

  * E-mail: jrgalloway@mdanderson.org (JRG-P); dkontoyi@mdanderson.org (DPK)

  Affiliation Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯